| This week's sponsor is Patheon, part of Thermo Fisher Scientific. | | | Quickly proving efficacy in First-in-Human clinical trials is a make-or-break milestone for small biopharms whose hopes hinge upon one or two molecules. Read how CDMOs are helping these cash-strapped companies get to clinic faster. |
Today's Rundown Gates Foundation’s $100M-a-year nonprofit biotech takes flight Sarepta poaches Biogen development executive for CMO position Ipsen moves U.S. headquarters to Kendall Square [Sponsored] It Might Be a Bumpy Ride: Why Life Sciences Companies Should Consider Embracing the New Wave of Change Advaxis cuts staff as it seeks partner for troubled cancer vaccine Alder brings on Juno executive as CEO to prep for its migraine launch EuroBiotech Report—Roche scraps drug, Gilead-Hookipa, Adaptimmune data, Servier office and Enyo financing FiercePharmaAsia—China’s data rule, Biocon-Mylan’s Lantus copy, Eisai-Biogen Alzheimer’s readout Chutes & Ladders—Celgene's shakeups continue Featured Story | | | Friday, June 8, 2018 The Bill & Melinda Gates Foundation has held a coming-out party for its nonprofit biotech startup. Equipped with plans to build a 120-person team and spend $100 million a year, the Gates Medical Research Institute will turn drug industry expertise and processes on intractable diseases that kill millions of people annually in low- and middle-income countries. |
|
|
| This week's sponsor is SNBL. | | | Does Your CNS Program Need a Boost? The Shortest Distance is a Straight Line. Nose-to-Brain
Brain delivery can be a hurdle for CNS drugs targeting unmet medical needs. Our technology can deliver your drug directly to the brain. Find out how! |
Top Stories Thursday, June 7, 2018 Sarepta brought on Biogen’s VP of late-stage programs, Gilmore O’Neill, as chief medical officer, after their previous hire left after 8 months. Friday, June 8, 2018 Ipsen is moving its U.S. headquarters to Kendall Square in Cambridge, Massachusetts. The French drugmaker is the latest in a series of European companies to pick the biotech hotspot as their U.S. base. Monday, June 4, 2018 Changes in technology and geopolitics, coupled with U.S. tax reform and new financial accounting standards, are creating disruption in accounting and financial reporting for life sciences companies. Friday, June 8, 2018 Almost a quarter of Advaxis' workforce is facing the chop as new CEO Ken Berlin scales back trials of lead cancer immunotherapy axalimogene filolisbac, currently under an FDA clinical hold. Friday, June 8, 2018 Alder BioPharmaceuticals poached Juno Therapeutics’ chief commercial officer to serve as president and CEO, adding operational expertise as it looks to submit its lead migraine treatment for the company’s first FDA approval. Thursday, June 7, 2018 In this week's EuroBiotech Report, Roche scraps a spinal muscular atrophy drug, Gilead bags Hookipa technology, Adaptimmune posts data and more. Friday, June 8, 2018 Experts argue China's new scientific data rule could stymie drug research collaboration; Mylan and Biocon's Lantus copycat was rejected by the FDA due to manufacturing problems; Eisai and partners reported positive clinical data for Alzheimer's and sleep disorder candidates. Friday, June 8, 2018 Celgene's shakeups continue with a new CFO, Zai Lab grabbed a top AZ executive, Axovant brought on a Spark co-founder as CTO, and Gilead promoted its top deal-maker—those moves plus more hirings, firings and retirings throughout the industry. | This week's sponsor is LabConnect. | | | SciOps Provides Solutions for Lost Samples, Missed Timelines and Scientific Personnel Needs
Managing outsourced studies can be challenging. Read how our team’s functional and strategic resourcing services allow you to focus on other core competencies. |
Enrollment Showcase | | | Sponsored by: Bioinformatics at UTHealth SBMI UTHealth SBMI now offers a M.S. track in clinical and translational bioinformatics. |
|
|
Resources Sponsored by: Blue Latitude Health Blue Latitude Health explores the commercial barriers and new stakeholder connections for pharma companies developing precision medicines, and reveals how to grasp novel opportunities in the new era of healthcare. Presented By: Covance A solid RBM plan will not only help you comply with the ICH guidelines, but will help you mitigate risks which could ultimately delay your trials and increase costs. Download today! Presented by: Patheon, part of Thermo Fisher Scientific “Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure. Sponsored by: Seton Hall Law 4-day interactive educational program trusted by multi-national companies as part of their compliance training for employees. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating globally. Visit event homepage for session topics. Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Innovation, Collaboration and Entrepreneurship in Drug Discovery June 28, 2018 | Cambridge, UK CBI’s 14th Annual Medical Device Compliance Congress (MDCC) June 14-15, 2018 | Chicago, IL Sensors Expo & Conference Conference & Expo: June 26-28, 2018 | Pre-Conference Symposia: June 25, 2018 | San Jose, CA Drug Development Boot Camp® 2018 – Register Now! November 14-15, 2018 | Boston, MA | Register now and start your pre-Boot Camp preparation Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA | Register and start preparing Today! |
